We then performed an 8-h killing assay of NK-92MI, CD19-CAR, CLDN6-CAR1 and CLDN6-CAR2 NK cells on the 4 ovarian cancer GL-expressing cell lines. This evidence concerns the gene CD19 and ovarian carcinoma.